<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Work Medical Technology Group Ltd Ordinary Shares — News on 6ix</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares</link>
<description>Latest news and press releases for Work Medical Technology Group Ltd Ordinary Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 29 Dec 2025 14:35:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/work-medical-technology-group-ltd-ordinary-shares" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835d9ab78dffbe2df123243.webp</url>
<title>Work Medical Technology Group Ltd Ordinary Shares</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares</link>
</image>
<item>
<title>WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-grants-east-china-exclusive-distribution-rights-for-ai-automated-blood-cell-morphology-analyzer-sets-rmb10-million-sales-target-for-2026</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-grants-east-china-exclusive-distribution-rights-for-ai-automated-blood-cell-morphology-analyzer-sets-rmb10-million-sales-target-for-2026</guid>
<pubDate>Mon, 29 Dec 2025 14:35:00 GMT</pubDate>
<description>Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd. (“Hunan Saitumofei”) has entered into a one-year exclusive distribution agreement (the “Agreement”) with Shanghai Benk</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-subsidiary-obtains-manufacturing-approval-for-its-ai-automated-blood-cell-morphology-analyzer</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-subsidiary-obtains-manufacturing-approval-for-its-ai-automated-blood-cell-morphology-analyzer</guid>
<pubDate>Mon, 29 Dec 2025 14:00:00 GMT</pubDate>
<description>Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Co., Ltd., has received manufacturing approval from the Hunan Provincial Medical Products Administration for its Class II medical device, the Artificial Intelligen</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-1-for-100-reverse-stock-split-effective-december-29-2025</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-1-for-100-reverse-stock-split-effective-december-29-2025</guid>
<pubDate>Wed, 24 Dec 2025 16:30:00 GMT</pubDate>
<description>Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis (the “Reverse Stock Split”). The Company’s Class A ordinary shares will begin trading on a post-split basis when th</description>
</item>
<item>
<title>WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltds-subsidiary-retains-a-usdollar114000-service-contract-from-gempharmatech-corporation</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltds-subsidiary-retains-a-usdollar114000-service-contract-from-gempharmatech-corporation</guid>
<pubDate>Tue, 04 Nov 2025 14:00:00 GMT</pubDate>
<description>Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today is pleased to announce that its subsidiary, Neologics Bioscience Inc. (“Neologics”), has entered into a key service agreement (the “Agreement”) with GemPharmatech Corporation (“GemPharmatech”), a Delaware-based</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-usdollar1-million-equity-investment-in-neologics-bioscience</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-usdollar1-million-equity-investment-in-neologics-bioscience</guid>
<pubDate>Tue, 21 Oct 2025 13:00:00 GMT</pubDate>
<description>Hangzhou, China, Oct. 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an investment agreement (the “Investment Agreement”) with Neologics Bioscience Inc. (“Neologics”), a Delaware-based medical technology company specializing in research and deve</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-1-for-100-reverse-stock-split-effective-october-21-2025</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-1-for-100-reverse-stock-split-effective-october-21-2025</guid>
<pubDate>Thu, 16 Oct 2025 20:10:00 GMT</pubDate>
<description>Hangzhou, China, Oct. 16, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis (the “Reverse Stock Split”). The Company’s Class A ordinary shares will begin trading on a post-split basis when th</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-receipt-of-delisting-determination-letter-from-nasdaq</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-receipt-of-delisting-determination-letter-from-nasdaq</guid>
<pubDate>Tue, 14 Oct 2025 20:10:00 GMT</pubDate>
<description>Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a determination letter, dated October 9, 2025 (the “Letter”), from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of Na</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-granted-additional-180-day-period-to-regain-nasdaq-compliance</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-granted-additional-180-day-period-to-regain-nasdaq-compliance</guid>
<pubDate>Fri, 10 Oct 2025 13:00:00 GMT</pubDate>
<description>Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an additional 180-calendar-day period to regain compliance with the minimum bid price require</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-pricing-of-dollar29-million-registered-direct-offering</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-pricing-of-dollar29-million-registered-direct-offering</guid>
<pubDate>Thu, 25 Sep 2025 17:10:00 GMT</pubDate>
<description>Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company’s Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Partners with Hong Kong Web3.0 Standardization Association to Collaborate on Blockchain and RWA Innovations</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-partners-with-hong-kong-web30-standardization-association-to-collaborate-on-blockchain-and-rwa-innovations</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-partners-with-hong-kong-web30-standardization-association-to-collaborate-on-blockchain-and-rwa-innovations</guid>
<pubDate>Wed, 24 Sep 2025 04:00:00 GMT</pubDate>
<description>Hangzhou, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-partners-with-wuxi-branch-of-ruijin-hospital-shanghai-jiao-tong-university-school-of-medicine-to-develop-ai-applications-in-healthcare</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-partners-with-wuxi-branch-of-ruijin-hospital-shanghai-jiao-tong-university-school-of-medicine-to-develop-ai-applications-in-healthcare</guid>
<pubDate>Mon, 22 Sep 2025 13:00:00 GMT</pubDate>
<description>Hangzhou, China, Sept. 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. (“Work Hangzhou”) and its subsidiaries in China, today announced the signing of a strategic cooperation agreement (the “Agreement”) between Work Hangzhou and the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine (“Xin</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Closing of Registered Offering</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-closing-of-registered-offering</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-closing-of-registered-offering</guid>
<pubDate>Thu, 22 May 2025 20:10:00 GMT</pubDate>
<description>Hangzhou, China, May 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the closing of a registered offering (the “Offering”) of 10,000,000 ordinary units (the “Ordinary Units”) at an offering price of $0.50 per Ordinary Unit. Each Ordinary Unit consists of one Class A ordi</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Pricing of Registered Offering</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-pricing-of-registered-offering</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-pricing-of-registered-offering</guid>
<pubDate>Wed, 21 May 2025 13:00:00 GMT</pubDate>
<description>Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the pricing of a registered offering (the “Offering”) of 10,000,000 ordinary units (the “Ordinary Units”) or pre-funded units (the “Pre-funded Units”) in lieu thereof at an offering price of $0.50 per O</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-receives-nasdaq-notification-regarding-minimum-bid-price-deficiency</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-receives-nasdaq-notification-regarding-minimum-bid-price-deficiency</guid>
<pubDate>Fri, 11 Apr 2025 20:01:00 GMT</pubDate>
<description>Hangzhou, China, April 11, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on April 7, 2025, notifying the Company that it is not in compliance with the minimum bi</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-implementation-of-dual-class-share-structure-effective-march-6-2025</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-implementation-of-dual-class-share-structure-effective-march-6-2025</guid>
<pubDate>Wed, 05 Mar 2025 21:01:00 GMT</pubDate>
<description>Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the implementation of its dual-class share structure, effective March 6, 2025. About WORK Medical Technology Group LTD WORK Medical Technology Group LTD is a supplier of medical devices that develops and manuf</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-strategic-partnership-with-shanghai-chartwell-medical-device-co-ltd</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-strategic-partnership-with-shanghai-chartwell-medical-device-co-ltd</guid>
<pubDate>Fri, 28 Feb 2025 14:00:00 GMT</pubDate>
<description>Hangzhou, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd. (“Chartwell Medical”), a high-end medical products manufacturer across diverse fields, including nuclear medicine, imaging, infection con</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd. </title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-strategic-partnership-with-shanghai-chartwell-medical-device-co-ltd-1</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-strategic-partnership-with-shanghai-chartwell-medical-device-co-ltd-1</guid>
<pubDate>Fri, 28 Feb 2025 05:00:00 GMT</pubDate>
<description>Hangzhou, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-reports-financial-results-for-fiscal-year-2024</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-reports-financial-results-for-fiscal-year-2024</guid>
<pubDate>Fri, 14 Feb 2025 05:00:00 GMT</pubDate>
<description>HANGZHOU, China, Feb. 14, 2025 /PRNewswire/ -- WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (Nasdaq: WOK), a supplier of medical</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-partial-exercise-of-underwriters-over-allotment-option</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-partial-exercise-of-underwriters-over-allotment-option</guid>
<pubDate>Thu, 29 Aug 2024 04:00:00 GMT</pubDate>
<description>Hangzhou, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China,</description>
</item>
<item>
<title>WORK Medical Technology Group LTD Announces Closing of Initial Public Offering</title>
<link>https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-closing-of-initial-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/work-medical-technology-group-ltd-ordinary-shares/news/work-medical-technology-group-ltd-announces-closing-of-initial-public-offering</guid>
<pubDate>Mon, 26 Aug 2024 04:00:00 GMT</pubDate>
<description>Hangzhou, China, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the "Company"), a supplier of medical devices in China,</description>
</item>
</channel>
</rss>